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Introduction 
Chronic kidney disease is a worldwide problem 
which is rapidly increasing.1-3 In the United States the 
incidence and prevalence of end stage renal disease has 
doubled in the last ten years and is expected to continue 
rising in the future.4-5 In Malta the high prevalence of 
diabetes and the ageing population has similarly resulted 
in a significant increase in patients requiring 
haemodialysis over the last decade.6 Despite advances in 
dialysis and transplantation, prognosis has not improved 
worldwide.7 
Creation of an arteriovenous fistula is recognized to 
be the optimal vascular access for dialysis.8 The National 
Kidney Foundation – Kidney Disease Outcome 
Qualitative Initiative (KDOQI) guidelines state that 
when a patient reaches CKD stage 4 or 5, the forearm 
and upper limb veins should not be used for 
venipuncture, peripheral cannulation, peripheral venous 
catheter insertion or central lines. This is important, as it 
might render potential veins inadequate for fashioning of 
a primary fistula.9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients who require dialysis without established 
access, have significantly increased risk of mortality and 
morbidity compared with those who have a functioning 
fistula at first dialysis.10-13 The National Service 
Framework in the UK identified that access needs to be 
achieved some months in advance of its anticipated need.  
The K-DOQI guidelines state that patients, who are at 
late stage chronic kidney disease, should have an 
arteriovenous fistula fashioned at least six months prior 
to needling of the fistula, to obviate the use of other 
types of vascular access.14 
Patients should have fully functional permanent 
access, by the time dialysis is required. Being functional 
implies that it not only delivers adequate blood flow but 
that it should also be easily needled. For this to be met 
the diameter should be  around 0.6 cm, depth of 0.6 cm 
and a minimum flow volume of approximately 600 
ml/min2. 
Referral for creation of an autologous fistula should 
be made early enough to allow for maturation time as 
well as the possibility of access failure and 
refashioning .9 
The prevalence of diabetes in the Maltese 
population is high. This cohort of patients is being 
serviced by only one main teaching hospital, Mater Dei 
Hospital.  There are currently five consultant 
nephrologists (four consultants catering for the adult 
population and one paediatric consultant) responsible for 
patients with renal pathology. Patients undergo 
haemodialysis either at the renal unit at Mater Dei 
Hospital or at a small satellite unit at Gozo General 
Hospital on the island of Gozo. Patients requiring 
dialysis are referred to a vascular surgeon for assessment 
and creation of an arteriovenous fistula. These cases are 
discussed by the Renal Committee which is made up of 
nephrologists, surgeons and renal nurses. Patients 
referred for assessment for arteriovenous fistula 
fashioning are given priority and are seen on an urgent 
basis and given a date for surgery within two to three 
weeks of assessment. 
The aims of this study were to assess patency rates 
of autologous arteriovenous fistulae created at Mater Dei 
Hospital, utilization of these fistulae, interventions 
required to maintain patency and timing of referral for 
fashioning of dialysis access.  
 
Method 
A retrospective analysis of prospectively collected 
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data of patients who underwent primary fashioning of an 
autologous arteriovenous fistula, under the care of one 
vascular surgeon at Mater Dei Hospital, between 
October 2012 and May 2014 was performed.  
Data collected included demographics (gender and age),  
major risk factors for arterial disease (smoking, 
hypertension, hypercholesterolemia, diabetes and 
ischemic heart disease), presence of coagulation 
disorders, estimated glomerular filtration rate at time of 
referral, time period when fistula was fashioned, whether 
the patient was already on dialysis prior to surgery and 
type of fistula created. This data was collected 
prospectively and recorded in a vascular database. Other 
data collected included type of autologous AV fistula 
created. Details on maturation, patency, usability, 
successful cannulation and measurement of fistulae 
(diameter, depth, flow volume and peak systolic velocity 
(PSV)) was also recorded. Details on any reinterventions 
that were required were also recorded.   
The case files were reviewed at the Renal Unit, 
between August and September 2014 to identify the 
maturation, patency, usability, success of cannulation 
and any problems encountered before and after 
cannulation. Case files of deceased patients were 
reviewed, at the Mater Dei Hospital Medical Records, in 
September 2014 to identify the cause and the time lapse 
from fistula creation to the date of demise.  
A proforma was constructed to ensure thorough 
comprehensive data gathering. All data was finally 
inputted in an excel sheet and coded for easier data 
analysis.  
 
Results  
 Between October 2012 and May 2014, sixty eight 
patients underwent primary fashioning of an autologous 
arteriovenous fistula. Forty nine (72.1%) were male. The 
mean age was 60.9 years with a range from 14 to 90 
years. As illustrated in figure 1 eleven patients (16.2%) 
passed away during the study period with a median 
follow up of 14 weeks and a range from three days to 
fifty two weeks. Of these eleven, three (27.3%) passed 
away in the early post-operative period (within 30 days) 
as a result of myocardial infarctions or pulmonary 
embolism.  
Sixteen (23.5%) were current or previous smokers, 
sixty (88.2%) were known hypertensive on treatment, 
thirty seven (54.4%) had hypercholesterolemia and 
eighteen (26.5%) were known to suffer from ischemic 
heart disease having undergone previous surgery or 
percutaneous coronary intervention. Thirty eight 
(55.8%) patients were diabetic; of these three (7.89%) 
were diet controlled, nineteen (50%) were on oral 
hypoglycaemic agents and sixteen (42.1%) on insulin. 
Six (8.82%) were on anti-coagulation treatment upon 
referral. 
 
Figure 1: Graph showing outcome versus number of 
patients 
 
 
 
 
 
 
 
 
 
 
 
 
The mean estimated glomerular filtration rate 
(eGFR) at referral was 11.9 mls/min/1.73m2 with a 
range from 5-35mls/min/1.73m2. The vast majority, 
fifty one (75%), were already on dialysis at referral. 
Thirty seven (72.5%) were dialysed through a 
central venous catheter and fourteen (27.59%) via 
peritoneal dialysis. Nine (13.2%) had a fistula 
fashioned six months before initiation of dialysis 
while eight (11.8%) had a fistula created within six 
months of commencing dialysis (Figure 3). Only 
25% had a functioning fistula at the time of 
initiation of dialysis. 
All patients were examined preoperatively and 
also underwent duplex scanning of the upper limbs. 
Of the arteriovenous fistulae created, forty nine 
(72.1%) were brachiocephalic, ten (14.7%) radio 
cephalic fistulae, six (8.82%) transposed 
brachiobasilic fistulae, two (2.94 %) ulnar cephalic 
fistulae and one (1.47%) snuff box fistula, as shown 
in figure 2. 
 
Figure 2: Type of AV Fistulae fashioned 
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Figure 3: Status of patients upon referral of fashioning 
of AV fistula 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The autologous fistulae were assessed using duplex 
scanning in the early postoperative period to assess for 
maturation. The measurements were; mean diameter 
5.76 mm, mean depth 6.37 mm, flow volume 1.87 L/min 
and peak systolic volume (PSV) 282.85 m / sec.  
Excluding those patients who passed away in the 
immediate post-operative period, forty three fistulae 
(66.2%) matured by six weeks while twenty two did not 
(33.8%). The median follow up was of thirty eight 
weeks with a range from three weeks to eighty nine 
weeks. Fifty four fistulae (83.1%) were patent and forty 
nine (75.4%) were successfully cannulated. To date six 
fistulae (9.23%) were not used. Excluding those six 
fistulae and those that passed away in the immediate 
post-operative period, forty seven fistulae (79.7%) had 
successful first time cannulation while twelve (20.3%) 
did not. 
Twenty nine (44.6%), did not require any 
subsequent interventions. Eight fistulae (12.3%) required 
interventions before cannulation, twenty (30.7%) after 
cannulation and two (3.07%) needed both. As shown in 
table 1, before cannulation three required endovascular 
interventions, four open surgery and one needed both. 
After cannulation fourteen fistulae required 
endovascular interventions, five open surgery and one 
needed both.  
 
Table 1: Intenterventions prior and after cannulation (Excluding two patients that needed intervention both before 
and after cannulation) 
 
 
 
 
 
 
 
 
 
Discussion 
The patency rates of autologous 
arteriovenous fistulae fashioned at Mater Dei 
Hospital (83.1%) are comparable to those reported 
in the literature (between 43% and 85% one year 
patency).15-17 
Locally the majority of patients (75%) were 
already on some form of renal replacement therapy 
when referred for fistula creation with the majority 
being dialysed through a central venous catheter. 
The mean eGFR was 11.9 mls/min/1.73m2 at 
referral indicating late referral.  Early referral for 
fashioning of an arteriovenous fistula is 
recommended both by K-DOQI guidelines as well 
as local National Service Frameworks. Lack of a 
usable fistula for dialysis necessitates insertion of 
temporary lines which is associated with a 
significant increase in morbidity and mortality in 
this cohort of high risk patients.   
In the majority of patients the timing of dialysis 
requirement can be predicted, while in a small 
proportion this is not possible. Referral as early as 
one year prior to predicted requirement for dialysis, 
ensures that there is adequate time for fashioning 
and maturation of an AV fistula as well as the 
possibility of failure and refashioning. This obviates 
the need for potentially dangerous insertion of 
central venous catheters and their associated 
complications, particularly line sepsis, bacteraemia 
and mortality in the short-term and the long-term 
complications of central vein stenosis and 
occlusions.  
Early referral also ensures that acute 
admissions to hospital secondary to line 
complications are reduced and therefore 
unnecessary cannulation of arm veins with resultant 
loss of dialysis access possibilities is avoided.  
Furthermore in those patients who are already on 
 Before Cannulation After Cannulation 
 Endovascular 
Repair 
Open 
Repair 
Needing 
Both 
Endovascular 
Repair 
Open 
Repair 
Needing 
Both 
Number of patients 3 4 1 14 5 1 
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haemodialysis, once the AV fistula is created there 
is often pressure for early cannulation before 
adequate maturation of the fistula is achieved.  
There is clear evidence that early needling leads to a 
higher rate of fistula failure.8  
Late referral of patients also results in a 
significant number of unnecessary interventions by 
interventional radiologists such as insertion of 
tunnelled lines, which could be avoided.  This 
implies unnecessary utilisation of scarce resources 
from other departments, apart from the patients’ 
morbidity associated with the additional 
interventions. 
The proportion of patients in this study with a 
functioning AV fistula at time of first dialysis is 
very low (25%) and certainly well below current 
recommendations.  Reasons for this may include 
delay in diagnosis due to inadequate primary care 
facilities, inappropriate delay in referral to tertiary 
hospital, reluctance by patients to be referred, 
patient failure to accept dialysis or dialysis access, 
service provision pressures to increase peritoneal 
dialysis use, bureaucratic delays, poor 
communication between physicians and surgeons, 
and other factors.  Further studies need to be carried 
out to identify the causes of delay in referral in 
order to improve the current quality of care. 
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